{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "Science Desk", "lead_paragraph": "WHEN Dr. Brian L. Strom gives talks to medical groups, he shows a slide of the Food and Drug Administration's form for reporting adverse reactions to drugs. ''How many of you have ever seen that?'' he asks the doctors in the audience. On average, fewer than a third raise their hands. And therein lies a problem. Although reports from doctors are the Federal agency's main means of learning about adverse reactions to drugs that have been approved for marketing, ''most doctors don't know the system exists,'' said Dr. Strom, who heads the department of biostatistics and epidemiology at the University of Pennsylvania.", "headline": {"main": "The F.D.A. Approves a Drug. Then What?"}, "abstract": "Food and Drug Administration's practice of approving a drug and then getting feedback about adverse reactions to it come under renewed criticism in wake of agency's request that the diet pills fenfluramine and dexfenfluramine be taken off the market and its tentative approval of thalidomide for treatment of leprosy; advocates of current system say that discovery of diet pill problem shows that system works; its critics say that experience may be a harbinger of even worse problems with drugs like thalidomide; thalidomide's maker will monitor use of drug, notorious for causing devastating birth defects (L)", "print_page": "1", "word_count": 1596, "_id": "4fd200ce8eb7c8105d764447", "snippet": "WHEN Dr. Brian L. Strom gives talks to medical groups, he shows a slide of the Food and Drug Administration's form for reporting adverse reactions to drugs.  ''How many of you have ever seen that?'' he asks the doctors in the audience. On average,...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/1997/10/07/science/the-fda-approves-a-drug-then-what.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "organizations", "value": "FOOD AND DRUG ADMINISTRATION"}, {"name": "subject", "value": "BIRTH DEFECTS"}, {"name": "subject", "value": "WEIGHT"}, {"name": "subject", "value": "THALIDOMIDE (DRUG)"}, {"name": "subject", "value": "LEPROSY (HANSEN'S DISEASE)"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "DEXFENFLURAMINE (DRUG)"}, {"name": "subject", "value": "RECALLS AND BANS OF PRODUCTS"}, {"name": "subject", "value": "FENFLURAMINE (DRUG)"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Gina", "lastname": "KOLATA"}], "original": "By GINA KOLATA"}, "document_type": "article", "pub_date": "1997-10-07T00:00:00Z", "section_name": "Science; Health"}], "meta": {"hits": 1, "offset": 0, "time": 22}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}